“….[it] highlights once more the extraordinary contributions ERIC makes to the standardization of key laboratory data in CLL including IGHV sequencing, diagnostic flow cytometry, and the detection of minimal residual disease.” (A. Wiestner, Haematologica 2021)

IG NETWORK
READ MORE
TP53 NETWORK
READ MORE
  • ERIC will cover the cost for the low-medium income countries applying for EQA Process. We are also happy to take into consideration other requests based on objective needs of support. Please contact ERIC Office (office@ericll.org).